References
- Anastasi J., Bauer K.D., Variakojis D. DNA aneuploidy in Hodgkin's disease. Am. J. Pathol 1987; 128: 573–582
- Diamond L.W., Nathwani B.N., Rappaport H. Flow cy-tometry in the diagnosis and classification of malignant lymphoma and leukemia. Cancer 1981; 50: 1122–35
- Joenssu H., Klemi P.J., Eerola E. Diagnostic value of DNA flow cytometry combined with fine needle aspiration biopsy in lym-phomas. J. Pathol 1988; 154: 237–45
- Joenssu H., Klemi P.J., Korekeila E. Prognostic value of DNA ploidy and proliferative activity in Hodgkin's disease. Am. J. Clin. Pathol. 1988; 90: 670–3
- Lehtinen T., Lehtinen M., Aine R., et al. Quantity of nuclear DNA in malignancies and benign lymphadenopathies associated with Epstein-Barr virus. J. Clin. Pathol. 1989; 42: 699–704
- Morgan K.G., Quirke P., O'Brien C.J., Bird C.C. Hodgkin's disease: a flow cytometric study. J. Clin. Pathol. 1988; 41: 365–9
- Erdkamp F.L., Schouten H.C., Breed W.P., et al. DNA aneuploidy in Hodgkin's disease: a multiparameter flow cytometric analysis. Leukemia and Lymphoma 1994; 12: 197–206
- Bauer K., Bagwell B., Giaretti W., et al. Consensus review of the clinical utility of DNA flow cytometry in colorectal cancer. Cytometry 1993; 14: 486–91
- Erdkamp F., Breed W., Schouten H. DNAaneuploidy and cell proliferation in relation to histology and prognosis in patients with Hodgkin's disease. Ann. Oncol 1993; 4: 75–80
- Hiddeman W., Schumann J., Andreeff M., et al. Convention of nomenclature for DNA cytometry. Cytometry 1984; 5: 445–6
- Baisch H., Gohde W., Linden W.A. Analysis of PCP-data to determine the fraction of cells in the various phases of the cell cycle. Rod. and Environm. Biophys. 1975; 12: 31–9
- Shankey T.V., Rabinovitch P.S., Bagwell B., et al. Guidelines for implementation of clinical DNA cytometry. Cytometry 1993; 14: 472–7
- Horan P., Muirhead K., Slezak S. Standards and controls in flow cytometry. Flow cytometry and sortingSecond Edition, M. Melamed, P. Mullaney, M. Mendelsohn. J. Wiley & Sons Inc., New York 1991; 397–414